SCHEMBL18411596

SCHEMBL18411596

COc1cc(-c2cccc(-c3ccc(OCc4ccccc4)cc3)c2)ccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.59
▸ ERN1 O75460 1/20 0.55
▸ MGAM O43451 3/20 0.54
▸ GAA P10253 3/20 0.54
▸ SI P14410 3/20 0.54
▸ MGAM2 Q2M2H8 3/20 0.54
▸ GSK3B P49841 1/20 0.54
▸ BACE1 P56817 1/20 0.54
▸ PTGER4 P35408 1/20 0.51
▸ PTGER3 P43115 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ LMNA P02545 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ PTGS2 P35354 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50
▸ HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20971507 0.96 MCL1 (0.63) MCL1ERN1MGAMGAASI
SCHEMBL1550410 0.84 MAOB (0.58) MGAMGAASIMGAM2GSK3B
SCHEMBL21003759 0.83 NPC1 (0.56) ERN1MGAMGAASIMGAM2
SCHEMBL18625351 0.83 LMNA (0.73) MCL1MGAMGAASIMGAM2
SCHEMBL20971437 0.82 MCL1 (0.59) MCL1MGAMGAASIMGAM2
Monobenzone SCHEMBL7269913 0.81 LMNA (0.76) MCL1GAAPTGER4PTGER3MAPT
SCHEMBL18311383 0.81 ERN1 (0.50) ERN1PTGS1CYP2C19PTGS2FYN
SCHEMBL2524920 0.81 POLB (0.62) GAAMAPTLMNACYP1A2MAOB
SCHEMBL30957832 0.81 POLB (0.62) GAAMAPTLMNACYP1A2MAOB
SCHEMBL3302315 0.81 MCL1 (0.55) MCL1ERN1MAOBFFAR1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225606-B2 Polymerizable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2022-01-18 — — US disclosed
US-20200248078-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2020-08-06 — — US disclosed
EP-3121247-B1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2019-10-02 — — EP disclosed
US-20190256777-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2019-08-22 — — US disclosed
US-10344215-B2 Polymerizable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2019-07-09 — — US disclosed
EP-3121247-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS Merck Patent GmbH (DE) 2017-01-25 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225606-B2 Polymerizable compounds and the use thereof in liquid-crystal displays VCL, PLEC, EML4 MCL1 3415/4885ERN1 1131/4885MGAM 541/4885
US-10344215-B2 Polymerizable compounds and the use thereof in liquid-crystal displays VCL, PLEC, EML4 MCL1 3415/4885ERN1 1131/4885MGAM 541/4885
US-20190256777-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 MCL1 3415/4885ERN1 1131/4885MGAM 541/4885
US-20200248078-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 MCL1 3415/4885ERN1 1131/4885MGAM 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback